Tuesday, March 21, 2023
Clinical Advances in
Read Overview
Supported by an independent medical education grant from Astellas and Seagen Inc.
Steering Committee Member Chair
Professor of Genitourinary Oncology
Barts Cancer Institute
Queen Mary University of London
London, United Kingdom
Director of the Medical Oncology Program
Clinical Research lead
MD Anderson Cancer Center Madrid
Madrid, Spain
Department of Cancer Medicine
Université Paris-Saclay
Institut Gustave Roussy
Villejuif, France
Associate Professor
Director of Genitourinary Medical Oncology
Vita-Salute San Raffaele University
IRCCS San Raffaele Hospital
Milan, Italy
Professor and Vice Chairman
Department of Urology
Eberhard Karls University Tübingen
Tübingen, Germany
Medical Oncologist
Chief, Genitourinary Medical Oncology Service
Division of Solid Tumor Oncology
Enno W. Ercklentz Chair
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Professor of Medicine and Urology
Smilow Cancer Hospital
Yale University
New Haven, Connecticut, United States
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Astellas; AstraZeneca; Bristol Myers Squibb; Eisai; Exelixis; Incyte; Ipsen; Johnson & Johnson; Merck; Merck Serono; MSD; Novartis; Pfizer; Roche; Seattle Genetics
Received grants for clinical research from: Astellas; AstraZeneca; Bristol Myers Squibb; Eisai; Exelixis; Ipsen; Johnson & Johnson; Merck; Merck Serono; MSD; Novartis; Pfizer; Roche; Seattle Genetics
Other: Travel/Accomodtion/Expenses: AstraZeneca; Ipsen; MSD; Pfizer; Roche
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Eisai; Esteve; Lilly; Merck KGaA; MSD; Novartis; Pfizer; Roche
Served as a speaker or a member of a speakers bureau for: Adacap; Amgen; Angelini; Astellas; AstraZeneca; Bayer; Blueprint; Bristol Myers Squibb; Caris Life Sciences; Celgene; Clovis-Oncology; Eisai; Eusa Pharma; Genetrcer; GlaxoSmithKline; Guardnt Health; HRA-Pharma; Ipsen; ITM Radiopharma; Janssen; Lexion; Lilly; Merck KGaA; MSD; Nanostring Technologies; Natera; Novartis; ONCODNA (biosequence); Palex; Pharmamar; Pierre Fabre; Pfizer; Roche; Sanofi-Genzyme; Servier; Taiho; Thermo Fisher Scientific
Received grants for clinical research from: Astellas; AstraZeneca; Ipsen; Lexicon; Merck KGaA; MTEM/Threshold; Nanostring Technologies; Pfizer; Roche
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Astellas; AstraZeneca; Bristol Myers Squibb; Gilead; Janssen; Merck KGaA; MSD; Pfizer; Roche; Sanofi; Seattle Genetics; Tahio
Received grants for clinical research from: Celsius; Janssen; MSD; Sanofi
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AstraZeneca; Bayer; Bristol Myers Squibb; Clovis Oncology; Incyte; Janssen; Merck; Rainier Therapeutics; Roche; Seattle Genetics/Astellas
Received grants for clinical research from: AstraZeneca; Foundation Medicine; Janssen; Merck; Roche
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Astellas; Bristol Myers Squibb; Eisai; EUSA Pharma; Ipsen; Merck; Merck Sharpe & Dohme; Nektar; Pfizer; Roche
Served as a speaker or a member of a speakers bureau for: AstraZeneca; Astellas; Bristol Myers Squibb; Eisai; EUSA Pharma; Ipsen; Merck; Merck Sharpe & Dohme; Novartis; Pfizer; Roche
Received grants for clinical research from: Eisai; Ipsen; Merck Sharpe & Dohme; Novartis; Roche; Pfizer; Seagen
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Astellas; BioClin; Boehringer Ingelheim; Bristol Myers Squibb; EMD-Serono; GlaxoSmithKline; Immunomedics/Gilead; Janssen; Lilly; Merck; Mirati Therapeutics; Pfizer; Roche/Genentech; Seattle Genetics; Tyra Biosciences
Served as a speaker or a member of a speakers bureau for: Clinical Care Options; EMD-Serono; MJH Associates; OncLive; Physicians Education Resource
Received grants for clinical research from: Astellas; Roche/Genentech; QED; Seattle Genetics
Other: Uptodate
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AdaCap; Amgen; Astellas; AstraZeneca; Bayer; Bicycle Therapeutics; Boehringer Ingelheim; Bristol Myers Squibb; Clovis Oncology; Eli Lilly; Exelixis; Incyte; Ipsen; Janssen; Mirati; Monopteros; Pfizer; Pharmacyclics; Regeneron; Roche; Seattle Genetics; Urogen
Received grants for clinical research from: AdaCap; Agensys Inc.; Astellas; AstraZeneca; Bayer; BioXcel Therapeutics; Bristol Myers Squibb; Clovis Oncology; Eisai; Eli Lilly; Endocyte; Genentech; Innocrin; MedImmune; Medication; Merck; Mirati; Novartis; Pfizer; Progenics; Replimune; Roche; Sanofi Aventis; Seattle Genetics